Sera Prognostics, Inc.
NASDAQ:SERA · NASDAQ Global Market
-$0.03 today
Vol 0.07M · Avg 0.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-6.42%
Period High
$4.09
Period Low
$1.59
Latest
$1.75
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Apyx Medical Corporation
NASDAQ:APYX
$169.80M
Surrozen, Inc.
NASDAQ:SRZN
$169.44M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$150.61M
Lucid Diagnostics Inc.
NASDAQ:LUCD
$105.37M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$103.85M
Oncolytics Biotech Inc.
NASDAQ:ONCY
$96.49M
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$77.27M
SkyAI, Inc.
NASDAQ:STSS
$51.00M
Tevogen Bio Holdings Inc.
TVGN
$42.95M
Atossa Therapeutics, Inc.
ATOS
$17.35M
What is the latest SERA filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does SERA have?
Intrinsic Alpha currently shows 20 recent filings for SERA.
Explore More
Continue the stock analysis
Jump to another research area for this company.